Meet Our New Director of Sales for the Americas

13/11/2015

We are happy to introduce our new colleague, Faisal Mojaddidi, who’s originally from Afghanistan, and based in the US since an early age. Having a background in Psychology and Biology, Faisal is highly passionate about personalized medicine, and he will take care of sales activities as our new Director of...

ASHI 2015, y’all!

15/10/2015

The ASHI event went smashingly for Omixon yet again, with a full soccer-sized team of 11 making the trip from all corners of the US and across the pond from Europe – first to Atlanta, and then by minibus on a road trip to Savannah, Georgia. In among sweltering...

Towards a New Gold Standard – NGS Corrections to Sanger SBT Genotyping Results

13/10/2015

Authors: Efi Melista, Krisztina Rigo, Agnes Pasztor, Mette Christiansen, Francesca Eleonora Bertinetto, Peter Meintjes, Tim Hague Aim: HLA typing is a crucial step prior to transplantation, particularly for bone marrow transplants. Correct allele matching is essential in order to increase the success of transplantation outcomes and decrease the rate...

Omixon Holotype Early Access Program Featured at ASHI Annual Meeting 2015

23/09/2015

Omixon announce today that Holotype HLA™ and other Omixon products will be featured in four oral presentations and 12 poster presentations at the annual meeting of the American Society for Histocompatibility and Immunogenetics (ASHI) in Savannah, Georgia. Additionally, in the Tuesday Vendor Symposium, Omixon’s CEO, Tim Hague, will present extended...

Omixon Symposium at APHIA in Bangkok, Thailand

23/09/2015

Join us for the upcoming Omixon Symposium, “Introduction to Holotype HLA™ and EAP Success“, our very first event at APHIA in Bangkok! Date: Wednesday, October 14, 2015 Time: 1:00pm – 1:30pm ICT Venue: Mandarin Hotel, Bangkok Content Welcome & Introduction Presentation by Efi Melista & Marcello Scala Discussion,...